Nuvo Research, Inc.

Nuvo Research, Inc.

Sector: Pharmaceutical Preparations Region: Canada

: | OTC Markets: NRIFF | Toronto Stock Exchange: NRI

Similar to: AstraZeneca Plc, Skystar Bio-Pharmaceutical Co., Guerbet SA

Nuvo Research, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. The company operates its business through two segments: Pain Group and Immunology Group. The Pain Group is focused on the development and commercialization of topically delivered pain products. The Immunology group provides an essential defense to microorganisms, cancer and substances it sees as foreign and potentially harmful. Its product portfolio includes Pennsaid, Pliaglis and Synera. Pennsaid is used to treat the signs and symptoms of osteoarthritis of the knees. Pliaglis is a topical local anesthetic cream, which is Food and Drug Administration approved to provide topical local analgesia. Synera is a topical patch that combines lidocaine, tetracaine and heat, approved in the United States to provide local dermal analgesia for superficial venous access and superficial dermatological procedures. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada.

News & Analysis

You may also be interested in: